Horizon Medical Products Appoints Michael J. Mark As New Chief Operating Officer

Apr 24, 2001, 01:00 ET from Horizon Medical Products, Inc.

    ATLANTA, April 24 /PRNewswire Interactive News Release/ -- HMP - Horizon
 Medical Products, Inc. (Amex:   HMP) today announced the appointment of Michael
 J. Mark as Chief Operating Officer, a new position, effective immediately.
     Mr. Mark has assumed all management responsibility of the Company as it
 embarks on its new strategy of growth from within, rather than acquisitions.
 "Mark's proven medical engineering and developmental skills are just what we
 need to refocus our sales, marketing and manufacturing operations on higher-
 margin proprietary products," said Marshall B. Hunt," Horizon's Chairman and
 CEO.
     Mr. Mark, 58 years old, has spent 25 years at medical startups and
 turnaround situations, most recently as President and CEO of Catheter Imaging
 Systems, Inc., Atlanta.  In his eight years there, he successfully negotiated
 multi-year licenses and distribution agreements with major international
 companies, and invented and patented disposable catheter and fiber-optic
 imaging systems, while implementing high-volume and assembly capability.
     "I'm eager to implement a similar strategy here, as Horizon's new business
 plan also calls for bringing all manufacturing in-house by year-end," Mr. Mark
 added.  "I believe that my prior dealings with regulatory agencies and
 hospitals also suit a company whose most important products are validated in
 clinical trials."
     Previously, Mr. Mark was COO of Solos Endoscopy Inc., and President of the
 Chronos Richardson division of Staveley PLC, London.  He holds a Master's
 degree from the University of Darmstadt, Germany, and was a US Air Force
 Captain.  He lives in the Atlanta area with his wife, Ingrid Mark.
     Dick Redden, President and COO of The Osnos Group, a New York-based
 turnaround specialist, will continue to advise HMP management through the end
 of 2001.
 
     ABOUT HORIZON
     Horizon Medical Products, Inc. headquartered in Atlanta, is a specialty
 medical device company focused on manufacturing and marketing vascular access
 products.  The Company's oncology product lines include implantable ports,
 tunneled central venous catheters and stem-cell transplant catheters used
 primarily in cancer treatment protocols.  The Company also markets a complete
 line of acute and chronic dialysis catheters.
     Vortex(TM) Technology, which was introduced by Horizon Medical Products in
 March 2000, refers to the swirling blood flow produced by a uniquely rounded
 reservoir design and tangential outlet that virtually eliminates thrombosis,
 or the buildup of sludge from blood and drug byproducts, in the port
 reservoir, and reduces certain complications that require additional surgery.
 
     SAFE HARBOR: Certain statements and information included herein may
 constitute "forward-looking statements" which are made pursuant to the safe
 harbor provisions of the Private Securities Litigation reform Act of 1995.
 The forward-looking statements are based on current expectations and may be
 significantly impacted by certain risks and uncertainties described herein and
 various documents filed by the Company with the US Securities and Exchange
 Commission, including but not limited to the Company's Prospectus on Form S-1
 and the Company's Annual Report on Form 10-K for the year ended December 31,
 2000.  There can be no assurance that statements made in this press release
 relating to future events will be achieved.  The Company undertakes no
 obligation to update or revise forward-looking statements to reflect changed
 assumptions, the occurrence of unanticipated events or changes to future
 operating results over time.
 
     For further information, please contact Fred Biddle, Member of the Firm,
 Sitrick and Company, 310-788-2850, for Horizon Medical Products, Inc.
 
     CORPORATE WEBSITE:  http://www.hmpvascular.com
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X35447430
 
 

SOURCE Horizon Medical Products, Inc.
    ATLANTA, April 24 /PRNewswire Interactive News Release/ -- HMP - Horizon
 Medical Products, Inc. (Amex:   HMP) today announced the appointment of Michael
 J. Mark as Chief Operating Officer, a new position, effective immediately.
     Mr. Mark has assumed all management responsibility of the Company as it
 embarks on its new strategy of growth from within, rather than acquisitions.
 "Mark's proven medical engineering and developmental skills are just what we
 need to refocus our sales, marketing and manufacturing operations on higher-
 margin proprietary products," said Marshall B. Hunt," Horizon's Chairman and
 CEO.
     Mr. Mark, 58 years old, has spent 25 years at medical startups and
 turnaround situations, most recently as President and CEO of Catheter Imaging
 Systems, Inc., Atlanta.  In his eight years there, he successfully negotiated
 multi-year licenses and distribution agreements with major international
 companies, and invented and patented disposable catheter and fiber-optic
 imaging systems, while implementing high-volume and assembly capability.
     "I'm eager to implement a similar strategy here, as Horizon's new business
 plan also calls for bringing all manufacturing in-house by year-end," Mr. Mark
 added.  "I believe that my prior dealings with regulatory agencies and
 hospitals also suit a company whose most important products are validated in
 clinical trials."
     Previously, Mr. Mark was COO of Solos Endoscopy Inc., and President of the
 Chronos Richardson division of Staveley PLC, London.  He holds a Master's
 degree from the University of Darmstadt, Germany, and was a US Air Force
 Captain.  He lives in the Atlanta area with his wife, Ingrid Mark.
     Dick Redden, President and COO of The Osnos Group, a New York-based
 turnaround specialist, will continue to advise HMP management through the end
 of 2001.
 
     ABOUT HORIZON
     Horizon Medical Products, Inc. headquartered in Atlanta, is a specialty
 medical device company focused on manufacturing and marketing vascular access
 products.  The Company's oncology product lines include implantable ports,
 tunneled central venous catheters and stem-cell transplant catheters used
 primarily in cancer treatment protocols.  The Company also markets a complete
 line of acute and chronic dialysis catheters.
     Vortex(TM) Technology, which was introduced by Horizon Medical Products in
 March 2000, refers to the swirling blood flow produced by a uniquely rounded
 reservoir design and tangential outlet that virtually eliminates thrombosis,
 or the buildup of sludge from blood and drug byproducts, in the port
 reservoir, and reduces certain complications that require additional surgery.
 
     SAFE HARBOR: Certain statements and information included herein may
 constitute "forward-looking statements" which are made pursuant to the safe
 harbor provisions of the Private Securities Litigation reform Act of 1995.
 The forward-looking statements are based on current expectations and may be
 significantly impacted by certain risks and uncertainties described herein and
 various documents filed by the Company with the US Securities and Exchange
 Commission, including but not limited to the Company's Prospectus on Form S-1
 and the Company's Annual Report on Form 10-K for the year ended December 31,
 2000.  There can be no assurance that statements made in this press release
 relating to future events will be achieved.  The Company undertakes no
 obligation to update or revise forward-looking statements to reflect changed
 assumptions, the occurrence of unanticipated events or changes to future
 operating results over time.
 
     For further information, please contact Fred Biddle, Member of the Firm,
 Sitrick and Company, 310-788-2850, for Horizon Medical Products, Inc.
 
     CORPORATE WEBSITE:  http://www.hmpvascular.com
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X35447430
 
 SOURCE  Horizon Medical Products, Inc.